Price$32.86+0.11 (+0.34%)
01:30 PM07:45 PM
News · 26 weeks114-75%
2026-01-182026-07-12
Mix6190d
- Insider29(48%)
- Other17(28%)
- SEC Filings10(16%)
- Analyst2(3%)
- Earnings2(3%)
- Leadership1(2%)
Latest news
25 items- PRHims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the CompanyHims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced its Chief Accounting Officer, Irene Becklund will depart the company after more than seven years, effective October 9, 2026. Becklund will then serve as an advisor to the company for several months to assist with the transition. The company will conduct a search for her permanent successor, with Yemi Okupe, CFO of Hims & Hers, assuming the responsibilities of CAO in the interim. "Irene has left an indelible mark on Hims & Hers as a trusted leader whose expertise and judgment have been integral to our growth as a company. Over the last seven years, Irene has helped build and maintain the financi
- SECHims & Hers Health Inc. filed SEC Form 8-K: Leadership Update8-K - Hims & Hers Health, Inc. (0001773751) (Filer)
- PRHims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report second quarter 2026 financial results after the market closes on Monday, August 10, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. About Hims & Hers Health, Inc. Hims & Hers is the leading health and wellness platform on a missio
- INSIDERChief Financial Officer Okupe Oluyemi exercised 7,163 shares at a strike of $5.01 and sold $261,351 worth of shares (7,163 units at $36.49) as part of a pre-agreed trading plan (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- SECHims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Hims & Hers Health, Inc. (0001773751) (Filer)
- INSIDERChief Medical Officer Carroll Patrick Harrison sold $830,410 worth of shares (23,726 units at $35.00), decreasing direct ownership by 12% to 181,861 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Financial Officer Okupe Oluyemi exercised 6,376 shares at a strike of $5.01 and sold $619,217 worth of shares (18,197 units at $34.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 284,321 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Financial Officer Okupe Oluyemi converted options into 71,616 shares and covered exercise/tax liability with 39,541 shares, increasing direct ownership by 12% to 296,142 units (SEC Form 4) to cover withholding tax4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Medical Officer Carroll Patrick Harrison converted options into 25,926 shares and covered exercise/tax liability with 8,310 shares, increasing direct ownership by 9% to 205,587 units (SEC Form 4) (withholding tax)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Operating Officer Chi Michael covered exercise/tax liability with 47,699 shares, sold $441,850 worth of shares (14,027 units at $31.50) as part of a pre-agreed trading plan and converted options into 86,264 shares, increasing direct ownership by 6% to 432,124 units (SEC Form 4) (withholding obligation)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Policy Officer Autor Deborah M. covered exercise/tax liability with 15,396 shares and converted options into 32,919 shares, increasing direct ownership by 56% to 48,961 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERPAO Becklund Irene converted options into 15,971 shares, covered exercise/tax liability with 5,870 shares and sold $370,518 worth of shares (12,063 units at $30.72) as part of a pre-agreed trading plan, decreasing direct ownership by 22% to 6,790 units (SEC Form 4) (for tax liability)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Legal Officer Boughton Soleil converted options into 42,261 shares and covered exercise/tax liability with 23,315 shares, increasing direct ownership by 6% to 318,314 units (SEC Form 4) to cover taxes4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Executive Officer Dudum Andrew covered exercise/tax liability with 85,632 shares and converted options into 154,991 shares, increasing direct ownership by 8% to 957,043 units (SEC Form 4) (withholding tax)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERCTO Elshenawy Mohamed converted options into 282,597 shares, covered exercise/tax liability with 151,534 shares and sold $946,260 worth of shares (30,040 units at $31.50) as part of a pre-agreed trading plan (SEC Form 4) (tax withholding)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Wells David B converted options into 4,613 shares, increasing direct ownership by 2% to 229,030 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Perez Garcia Andrea G converted options into 3,656 shares, increasing direct ownership by 5% to 83,822 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Schultz Kare converted options into 3,656 shares, increasing direct ownership by 23% to 19,397 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Medical Officer Carroll Patrick Harrison converted options into 4,091 shares, increasing direct ownership by 2% to 187,971 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Policy Officer Autor Deborah M. converted options into 3,656 shares, increasing direct ownership by 13% to 31,438 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 3 filed by new insider Amoo-Gottfried Kofi Owusu3 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Payne Christopher D converted options into 14,343 shares, increasing direct ownership by 72% to 34,318 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Pendarvis Christiane converted options into 3,656 shares, increasing direct ownership by 7% to 55,430 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Manuel Anja converted options into 13,696 shares, increasing direct ownership by 55% to 38,671 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Cosgrove Delos M. converted options into 3,656 shares, increasing direct ownership by 6% to 67,995 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
HIMS FAQ
7 questionsWhat does Hims & Hers Health Inc. do?
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin...Where does HIMS stock trade?
Hims & Hers Health Inc. (HIMS) is listed on NYSE.What sector and industry is HIMS in?
Hims & Hers Health Inc. operates in the Health Care sector, Medical/Nursing Services industry.When did Hims & Hers Health Inc. go public?
Hims & Hers Health Inc. (HIMS) completed its IPO in 2019.What are analysts saying about HIMS?
Hims & Hers Health Inc. has had 8 recent analyst actions on file. The most recent action was from Needham: Buy with a $3500.00 price target on 2026-05-12. Recent price targets range from $2300.00 to $4800.00.What companies are similar to HIMS?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), CHE (Chemed Corp), LFST (LifeStance Health Group Inc.), AMED (Amedisys Inc), LHCG (LHC Group). Compare HIMS side-by-side with any of them on Quantisnow.How can I track HIMS on Quantisnow?
Quantisnow aggregates Hims & Hers Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HIMS to receive live email and push alerts on every new disclosure.